risks of taking compounded semaglutide FDA Warns on Certain Forms FDA Warns Against Using Compounded

Products that were once enjoyable may suddenly taste too sweet, leading to rejection rather than satisfaction, he said, adding, Subtle sweetness, savory or lightly salted profiles may perform well with this consumer group. The shift in taste may be surprising for consumers and may result in a narrowed diet if options arent aligned with their new sensory palate

These symptoms occurred largely during the dose-escalation period, were transient and mild/moderate in severity, and led to drug discontinuation in up to 7% of participants in each active therapy group

Nausea is the most common side effect, especially when starting treatment

doi: 10.1016/j.neuropharm.2020.108026 29